[18F]Flortaucipir binding and affinity to tau protein measured in postmortem human brains of Alzheimers disease and Down syndrome by autoradiography: Comparison with [ 18 F]MK-6240

Flortaucipir and MK-6240 are two tau imaging agents currently in use for measuring neurofibrillary tangle (NFT) progression in Alzheimers disease (AD). The aims of this study were to use postmortem AD and Down syndrome (DS) brain sections to study three issues: (1) Measure binding affinity of flortaucipir and MK-6240 in AD brain sections by using [125I]IPPI; (2) Evaluate the binding characteristics of [18F]flortaucipir in AD, DS and cognitively normal (CN) brains sections and compare them with [18F]MK-6240, and (3) Assess the binding of [18F]flortaucipir in CN and Parkinsons disease (PD) brain sections to identify any off-target binding. The half-maximal inhibition (IC50) of [125I]IPPI bound to anterior cingulate (AC) in AD brain sections for flortaucipir was 2.91 nM and MK-6240 was 5.99 nM. Using frontal cortex (FCX) and temporal cortex (TCX) of AD, DS and CN brain sections, [18F]flortaucipir displayed high levels of binding in the gray matter (GM) of AD and DS. The average ratio of DSAD GM to CN GM was 15.7 in FCX, while DSAD GM to CN GM was 15.2 for the TCX. In the case of AD, average ratio of AD GM to CN GM was 12.4 in FCX, while AD GM to CN GM was 9.5 for the TCX. Binding of [18F]flortaucipir in brain section of AC from CN and PD cases did not exhibit any off-target binding to monoamine oxidase-A (MAO-A). In summary, both flortaucipir and MK-6240 exhibit similar high affinity to tau and [18F]flortaucipir exhibits higher binding compared to [18F]MK-6240 in DSAD.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.15.766816
Primary Topic
Alzheimer's disease research and treatments
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

[18F]Flortaucipir binding and affinity to tau protein measured in postmortem human brains of Alzheimers disease and Down syndrome by autoradiography: Comparison with [ 18 F]MK-6240

Christopher Liang, Jogeshwar Mukherjee, Chloe C. McNamara, Emma Lynn M. Hipolito et al.
4 links
bioRxiv (Cold Spring Harbor Laboratory)
Alzheimer's disease research and treatments
preprint

[18F]Flortaucipir binding and affinity to tau protein measured in postmortem human brains of Alzheimers disease and Down syndrome by autoradiography: Comparison with [ 18 F]MK-6240

Christopher Liang, Jogeshwar Mukherjee, Chloe C. McNamara, Emma Lynn M. Hipolito, Agnes P. Biju, Josie M Herrera
preprint en

Abstract

Flortaucipir and MK-6240 are two tau imaging agents currently in use for measuring neurofibrillary tangle (NFT) progression in Alzheimers disease (AD). The aims of this study were to use postmortem AD and Down syndrome (DS) brain sections to study three issues: (1) Measure binding affinity of flortaucipir and MK-6240 in AD brain sections by using [125I]IPPI; (2) Evaluate the binding characteristics of [18F]flortaucipir in AD, DS and cognitively normal (CN) brains sections and compare them with [18F]MK-6240, and (3) Assess the binding of [18F]flortaucipir in CN and Parkinsons disease (PD) brain sections to identify any off-target binding. The half-maximal inhibition (IC50) of [125I]IPPI bound to anterior cingulate (AC) in AD brain sections for flortaucipir was 2.91 nM and MK-6240 was 5.99 nM. Using frontal cortex (FCX) and temporal cortex (TCX) of AD, DS and CN brain sections, [18F]flortaucipir displayed high levels of binding in the gray matter (GM) of AD and DS. The average ratio of DSAD GM to CN GM was 15.7 in FCX, while DSAD GM to CN GM was 15.2 for the TCX. In the case of AD, average ratio of AD GM to CN GM was 12.4 in FCX, while AD GM to CN GM was 9.5 for the TCX. Binding of [18F]flortaucipir in brain section of AC from CN and PD cases did not exhibit any off-target binding to monoamine oxidase-A (MAO-A). In summary, both flortaucipir and MK-6240 exhibit similar high affinity to tau and [18F]flortaucipir exhibits higher binding compared to [18F]MK-6240 in DSAD.

bioRxiv (Cold Spring Harbor Laboratory)
University of California, Irvine (US)
Arizona Department of Health Services, Arizona Biomedical Research Commission, National Institutes of Health, University of California, Irvine, National Institute on Aging
Good health and well-being
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon